Publication: Inhibition of cAMP-Activated Intestinal Chloride Secretion by Diclofenac: Cellular Mechanism and Potential Application in Cholera
Issued Date
2014-09-01
Resource Type
ISSN
19352735
19352727
19352727
Other identifier(s)
2-s2.0-84907587752
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
PLoS Neglected Tropical Diseases. Vol.8, No.9 (2014)
Suggested Citation
Pawin Pongkorpsakol, Nutthapoom Pathomthongtaweechai, Potjanee Srimanote, Sunhapas Soodvilai, Varanuj Chatsudthipong, Chatchai Muanprasat Inhibition of cAMP-Activated Intestinal Chloride Secretion by Diclofenac: Cellular Mechanism and Potential Application in Cholera. PLoS Neglected Tropical Diseases. Vol.8, No.9 (2014). doi:10.1371/journal.pntd.0003119 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/34200
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Inhibition of cAMP-Activated Intestinal Chloride Secretion by Diclofenac: Cellular Mechanism and Potential Application in Cholera
Other Contributor(s)
Abstract
© 2014 Pongkorpsakol et al. Cyclic AMP-activated intestinal Cl−secretion plays an important role in pathogenesis of cholera. This study aimed to investigate the effect of diclofenac on cAMP-activated Cl−secretion, its underlying mechanisms, and possible application in the treatment of cholera. Diclofenac inhibited cAMP-activated Cl−secretion in human intestinal epithelial (T84) cells with IC50of ∼20 µM. The effect required no cytochrome P450 enzyme-mediated metabolic activation. Interestingly, exposures of T84 cell monolayers to diclofenac, either in apical or basolateral solutions, produced similar degree of inhibitions. Analyses of the apical Cl−current showed that diclofenac reversibly inhibited CFTR Cl−channel activity (IC50∼10 µM) via mechanisms not involving either changes in intracellular cAMP levels or CFTR channel inactivation by AMP-activated protein kinase and protein phosphatase. Of interest, diclofenac had no effect on Na+-K+ATPases and Na+-K+-Cl−cotransporters, but inhibited cAMP-activated basolateral K+channels with IC50of ∼3 µM. In addition, diclofenac suppressed Ca2+-activated Cl−channels, inwardly rectifying Cl−channels, and Ca2+-activated basolateral K+channels. Furthermore, diclofenac (up to 200 µM; 24 h of treatment) had no effect on cell viability and barrier function in T84 cells. Importantly, cholera toxin (CT)-induced Cl−secretion across T84 cell monolayers was effectively suppressed by diclofenac. Intraperitoneal administration of diclofenac (30 mg/kg) reduced both CT and Vibrio cholerae-induced intestinal fluid secretion by ∼70% without affecting intestinal fluid absorption in mice. Collectively, our results indicate that diclofenac inhibits both cAMP-activated and Ca2+-activated Cl−secretion by inhibiting both apical Cl−channels and basolateral K+channels in intestinal epithelial cells. Diclofenac may be useful in the treatment of cholera and other types of secretory diarrheas resulting from intestinal hypersecretion of Cl−.